Sułowicz W - Search Results

1

[Evaluation of immunosuppressive treatment on homocystein levels in patients after kidney transplantation during a 2 year observation period].

Aksamit D, Janda K, Kuźniewski M, Krzanowski M, Ignacak E, Betkowska-Prokop A, Chowaniec E, Sułowicz W. Aksamit D, et al. Among authors: sulowicz w. Przegl Lek. 2012;69(11):1175-9. Przegl Lek. 2012. PMID: 23646442 Polish.

2

[Analysis of selected inflammatory markers in patients with stable renal graft (RTx) 36 months after transplantation].

Krzanowski M, Stompór T, Kuśnierz-Cabala B, Ignacak E, Sułowicz W, Naskalski JW. Krzanowski M, et al. Among authors: sulowicz w. Przegl Lek. 2006;63(8):597-601. Przegl Lek. 2006. PMID: 17441364 Polish.

3

[Chronic kidney disease in the source documentation of the outpatient clinic Department of Nephrology. Part II. Comparison of the three different methods of glomerular filtration rate estimation].

Kopeć J, Januszek R, Wieczorek-Surdacka E, Kuźniewski M, Sułowicz W. Kopeć J, et al. Among authors: sulowicz w. Przegl Lek. 2009;66(12):1011-9. Przegl Lek. 2009. PMID: 20514897 Polish.

4

[Chronic kidney disease (CKD) in source documentation of the outpatient clinic of the Department of Nephrology. Part III. CKD, comorbidities and performed surgical procedures].

Kopeć J, Januszek R, Kuźniewski M, Sułowicz W. Kopeć J, et al. Among authors: sulowicz w. Przegl Lek. 2010;67(2):95-102. Przegl Lek. 2010. PMID: 20557007 Polish.

5

[Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].

Janda K, Kraśniak A, Krzanowski M, Sułowicz W. Janda K, et al. Among authors: sulowicz w. Przegl Lek. 2010;67(3):187-91. Przegl Lek. 2010. PMID: 20687383 Review. Polish.

6

[Coincidence of HCV and HGV infections in hemodialysis patients].

Kopeć J, Janda K, Tabor-Ciepiela B, Krzanowski M, Sułowicz W. Kopeć J, et al. Among authors: sulowicz w. Przegl Lek. 2010;67(12):1229-36. Przegl Lek. 2010. PMID: 21591345 Polish.

7

[Types of hemodialysis vascular access in patients on renal replacement therapy and its complications during a one year observation period].

Krzanowski M, Janda K, Chowaniec E, Kuśnierz-Cabala B, Sułowicz W. Krzanowski M, et al. Among authors: sulowicz w. Przegl Lek. 2011;68(7):343-7. Przegl Lek. 2011. PMID: 22010469 Polish.

8

[Disadvantages and benefits of early initiation of dialysotherapy].

Janda K, Zarebski W, Sułowicz W. Janda K, et al. Among authors: sulowicz w. Przegl Lek. 2011;68(12):1190-2. Przegl Lek. 2011. PMID: 22519278 Review. Polish.

9

[Post transplant lymphoproliferative disorder (PTLD)--10 years follow-up].

Ignacak E, Betkowska-Prokop A, Kuźniewski M, Rudzki Z, Okoń K, Skotnicki A, Jurczak W, Kulig J, Czupryna A, Bucki J, Sułowicz W. Ignacak E, et al. Among authors: sulowicz w. Przegl Lek. 2011;68(12):1202-3. Przegl Lek. 2011. PMID: 22519281 Polish.

10

[Influence of elevated homocystein level and selected lipid parameters in kidney transplant patients on the progression of atherosclerotic changes assessed by intima-media thickness index (CCA-IMT)].

Janda K, Aksamit D, Drozdz M, Krzanowski M, Ignacak E, Kowalczyk-Michałek M, Tabor-Ciepiela B, Sułowicz W. Janda K, et al. Among authors: sulowicz w. Przegl Lek. 2012;69(9):670-4. Przegl Lek. 2012. PMID: 23401987 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters